Case Studies
View our latest case studies
Fluenz® Tetra: delivering near real-time safety surveillance across eight influenza seasons
Overview AstraZeneca approached the DSRU to design and conduct Enhanced (Passive) Safety Surveillance, or E(P)SS,[…]
View Case StudyHands on support for planning observational studies
We provide advice and hands-on support in pharmacoepidemiology, including planning and conducting observational studies.
View Case StudyMonitoring COVID-19 vaccine safety in real time: the UK AstraZeneca experience
View Case StudyRivaroxaban registries
View Case Study
Fentanyl buccal tablets
We were approached by a company which requested a drug utilisation and safety study for....
View Case Study
Extension of product licence
We were approached by a company which requested a CPRD study to support extension....
View Case Study
Systematic Literature Review on risk factors for myocarditis and pericarditis
The aim of this study was to understand risk factors for myocarditis and pericarditis following....
View Case Study
Use of CPRD data to monitor the safety of COVID-19 vaccines
The DSRU is collaborating with several other research institutions throughout Europe, under the VAccine monitoring....
View Case Study
Systematic review of NSAID safety to support reclassification application
We conducted a systematic review at the request of the marketing authorisation holder (MAH) on....
View Case Study